Explore the Global Frontotemporal Dementia (FTD) Management Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Frontotemporal Dementia (FTD) Management Market

Key Insight

Frontotemporal dementia (FTD) management sales will expand through 2036, with antidepressants holding 57.6% of the drug class type segment in 2026. The market is expected to reach USD 414.7 million by the end of 2026 and USD 656.5 million by 2036, creating an incremental opportunity of USD 241.8 million.

April 27, 2026

Anurag Sharma

310 Pages

Cite this Report

Frontotemporal Dementia (FTD) Management Market

https://www.futuremarketinsights.com/reports/frontotemporal-dementia-management-market

License

Buy Now

Summary ToC Companies

Key Players

Alector
Astellas Pharma Inc
AviadoBio
CervoMed
F. Hoffmann-La Roche Ag
GSK
GlaxoSmithKline Plc
Merck KGaA
NKGen Biotech
Passage Bio, inc
TauRx

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Frontotemporal Dementia (FTD) Management Market

Key Players

Similar Industry Reports